Cargando…

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention

Background: No risk model for predicting thrombocytopenia associated with periprocedural tirofiban exposure is available. The purpose of this study was to develop a simple clinical pre-procedure risk model based on pre-procedural characteristics for early prediction of thrombocytopenia before patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Yi-Hu, Yin, Wen-Jun, Gu, Zhi-Chun, Fang, Wei-Jin, Li, Dai-Yang, Hu, Can, Liu, Kun, Ma, Rong-Rong, Zhou, Ling-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295459/ https://www.ncbi.nlm.nih.gov/pubmed/30618750 http://dx.doi.org/10.3389/fphar.2018.01456

Ejemplares similares

Tirofiban-induced thrombocytopenia
por: Wang, Jun, et al.
Publicado: (2023)

Tirofiban: A Rare Cause of Thrombocytopenia in a Patient Undergoing Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
por: Wang, Ze-Mu, et al.
Publicado: (2023)

Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion
por: Li, Xiaoye, et al.
Publicado: (2019)

Case report: reuse of tirofiban leads to very severe thrombocytopenia
por: Li, Yuqing, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions
por: Januszek, Rafał, et al.
Publicado: (2018)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease
por: Ibrahim, Toni, et al.
Publicado: (2016)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
por: Ueki, Yasushi, et al.
Publicado: (2022)

LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention
por: Chen, Xuefeng, et al.
Publicado: (2021)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2021)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Jian, Wen, et al.
Publicado: (2020)

Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Shibata, Yohei, et al.
Publicado: (2017)

Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020)

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2020)

Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hu, Sigan, et al.
Publicado: (2018)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
por: Verdoia, M., et al.
Publicado: (2016)

Exploring the Association of Fibrinogen and CRP with the Clinical Spectrum of CAD and Periprocedural Outcomes in Patients Undergoing Percutaneous Coronary Interventions
por: Khandelwal, Vijay, et al.
Publicado: (2022)

Long-term outcomes of periprocedural coronary dissection and perforation for patients undergoing percutaneous coronary intervention in a Japanese multicenter registry
por: Kuno, Toshiki, et al.
Publicado: (2023)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty
por: Yurtdaş, Mustafa, et al.
Publicado: (2014)

Total Thrombus‐formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Oimatsu, Yu, et al.
Publicado: (2017)

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
por: Lee, Wonjae, et al.
Publicado: (2018)

Periprocedural Hemoglobin Drop and Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients
por: Lee, Kang Hyu, et al.
Publicado: (2010)

Predictive value of the age, creatinine and ejection fraction score in patients undergoing primary percutaneous coronary intervention with bail-out tirofiban therapy
por: Ösken, Altuğ, et al.
Publicado: (2021)

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
por: Ji, Zhen-Guo, et al.
Publicado: (2015)

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention
por: Chen, Zhongxiu, et al.
Publicado: (2021)

Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
por: Jiménez-Rodríguez, Gian-Manuel, et al.
Publicado: (2023)

Carbamazepine Induces Platelet Apoptosis and Thrombocytopenia Through Protein Kinase A
por: Xiao, Weiling, et al.
Publicado: (2021)

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Coronary plaque morphology on multi-modality imagining and periprocedural myocardial infarction after percutaneous coronary intervention()
por: Sato, Akira, et al.
Publicado: (2016)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)
por: Jiao, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mt64kedgra4uvhfcn3u2ifgaio